A recently published article by ToxStrategies scientists and others presents the systematic identification, appraisal, and integration of mechanistic data in an assessment of potential… read more
EpidStrategies, a division of ToxStrategies Inc., is founded on rigorous scientific principles that guide our research on complex health conditions. We are scientists… read more
ToxStrategies scientist Dr. Bill Rish is a co-author of a new article that demonstrates acceptably low doses of naturally occurring radiation (NORM) when… read more
A recently published article by ToxStrategies scientists, with Dr. Daniele Wikoff as lead author, presents the systematic identification, appraisal, and integration of mechanistic… read more
ToxStrategies was excited to exhibit, for the first time, at Supply Side West (SSW) on October 17 and 18, in Las Vegas. According… read more
Following implementation of the Hemp Farming Act, part of the Agricultural Improvement Act of 2018 (aka, “2018 Farm Bill”), interest in hemp-derived products,… read more
ToxStrategies scientists have published an article proposing an oral reference dose (RfD) for the per‐ and polyfluoroalkyl substance (PFAS) commonly known to as… read more
On August 1, 2019, the U.S. EPA announced a new website where visitors can view and search monthly updates for any active Premanufacture… read more
